We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer

This study is not yet open for participant recruitment.
Verified December 2012 by Byeong Woo Park, Severance Hospital
Sponsor:
ClinicalTrials.gov Identifier:
NCT01752686
First Posted: December 19, 2012
Last Update Posted: December 25, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Byeong Woo Park, Severance Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)